End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
399.4 EUR | -.--% | -.--% | +8.22% |
06-07 | Russian court orders $56 mln Landesbank Baden-Wuerttemberg asset seizure | RE |
05-30 | ESAB to Acquire Linde Industries Private in Bangladesh for Undisclosed Sum | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.07 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.22% | 208B | - | ||
+2.09% | 62.14B | A | ||
+51.04% | 8.7B | C+ | ||
-16.06% | 3.33B | D+ | ||
+14.04% | 3.2B | C- | ||
+18.35% | 3.23B | C+ | ||
-13.64% | 2.15B | - | ||
+4.27% | 2.16B | - | ||
+2.58% | 1.64B | - | - | |
-26.07% | 1.18B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- LIN Stock
- Ratings Linde plc